About This Test
This test is useful for assessing the risk of hereditary cancer. The test covers 200 genes targetting hereditary cancers. The genes selected are based on the NCCN guidelines and peer reviewed literature. The cancers covered are Breast, Ovarian, Uterine, Stomach, Endocrine Pancreas, Esophagus, Colorectal, Endometrium, Ovarian, Bone, Thyroid, Kidneys, Urinary tract, Lung, Prostate, Central nervous system, Head & Neck, Liver, Cervix, Exocrine Pancreas, Small Intestine, Blood, Soft tissue, Skin, Peripheral nervous system & Endocrine glands.
Home Collection
✓ Available
Reports Available In
37 Days
Preparation / Prerequisite
10 mL (8 mL min.) Whole blood in 1 Lavender Top (EDTA) tube. Ship immediately at 18–22°C. DO NOT REFRIGERATE OR FREEZE. Duly filled Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) is mandatory.
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
The OncoPro Hereditary Cancer Risk Panel (200 Genes) is important because it helps identify inherited genetic mutations that increase cancer risk, enabling early detection, prevention, and personalized management.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
